Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
Conditions
- Acute Leukemia
- Chronic Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasm
- Solid Tumors
- Lymphoma
- Plasma Cell Disorders
Sponsor
Genzyme, a Sanofi Company
Collaborators